Search Results - "Guigoni, Céline"

Altered D1 dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates by Guigoni, Céline, Doudnikoff, Evelyne, Li, Qin, Bloch, Bertrand, Bezard, Erwan

“…Abstract Dyskinesias represent a debilitating complication of levodopa therapy for Parkinson's disease (PD). While we recently demonstrated that…”
Get full text

Altered D 1 dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates by Guigoni, Céline, Doudnikoff, Evelyne, Li, Qin, Bloch, Bertrand, Bezard, Erwan

“…Dyskinesias represent a debilitating complication of levodopa therapy for Parkinson's disease (PD). While we recently demonstrated that levodopa-induced…”
Get full text

Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia by Aubert, Incarnation, Guigoni, Céline, Håkansson, Kerstin, Li, Qin, Dovero, Sandra, Barthe, Nicole, Bioulac, Bernard H., Gross, Christian E., Fisone, Gilberto, Bloch, Bertrand, Bezard, Erwan

“…Involuntary movements, or dyskinesia, represent a debilitating complication of levodopa therapy for Parkinson's disease. Although changes affecting D1 and D2…”
Get full text

Striatal Overexpression of ΔJunD Resets L-DOPA-Induced Dyskinesia in a Primate Model of Parkinson Disease by Berton, Olivier, Guigoni, Céline, Li, Qin, Bioulac, Bernard H., Aubert, Incarnation, Gross, Christian E., DiLeone, Ralph J., Nestler, Eric J., Bezard, Erwan

“…Involuntary movements, or dyskinesia, represent a debilitating complication of dopamine replacement therapy for Parkinson disease (PD). The transcription…”
Get full text

Involvement of canonical and non-canonical D1 dopamine receptor signalling pathways in L-dopa-induced dyskinesia by Guigoni, Céline, Bezard, Erwan

“…Chronic L-3,4-dihydroxyphenylalanine (L-dopa) treatment of Parkinson Disease (PD) often leads to debilitating involuntary movements, termed L-dopa-induced…”
Get full text

Enhanced Preproenkephalin-B–Derived Opioid Transmission in Striatum and Subthalamic Nucleus Converges Upon Globus Pallidus Internalis in L-3,4-dihydroxyphenylalanine–Induced Dyskinesia by Aubert, Incarnation, Guigoni, Céline, Li, Qin, Dovero, Sandra, Bioulac, Bernard H., Gross, Christian E., Crossman, Alan R., Bloch, Bertrand, Bezard, Erwan

“…A role for enhanced opioid peptide transmission has been suggested in the genesis of levodopa-induced dyskinesia. However, basal ganglia nuclei other than the…”
Get full text

Striatal Proteomic Analysis Suggests that First L-Dopa Dose Equates to Chronic Exposure by Scholz, Birger, Svensson, Marcus, Alm, Henrik, Sköld, Karl, Fälth, Maria, Kultima, Kim, Guigoni, Céline, Doudnikoff, Evelyne, Li, Qin, Crossman, Alan R., Bezard, Erwan, Andrén, Per E.

“…L-3,4-dihydroxypheylalanine (L-dopa)-induced dyskinesia represent a debilitating complication of therapy for Parkinson's disease (PD) that result from a…”
Get full text

Involvement of sensorimotor, limbic, and associative basal ganglia domains in L-3,4-dihydroxyphenylalanine-induced dyskinesia by Guigoni, Céline, Li, Qin, Aubert, Incarnation, Dovero, Sandra, Bioulac, Bernard H, Bloch, Bertrand, Crossman, Alan R, Gross, Christian E, Bezard, Erwan

“…Dyskinesia represents a debilitating complication of L-3,4-dihydroxyphenylalanine (L-dopa) therapy for Parkinson's disease. Such motor manifestations are…”
Get more information

Increased D 1 dopamine receptor signaling in levodopa‐induced dyskinesia by Aubert, Incarnation, Guigoni, Céline, Håkansson, Kerstin, Li, Qin, Dovero, Sandra, Barthe, Nicole, Bioulac, Bernard H., Gross, Christian E., Fisone, Gilberto, Bloch, Bertrand, Bezard, Erwan

“…Involuntary movements, or dyskinesia, represent a debilitating complication of levodopa therapy for Parkinson's disease. Although changes affecting D 1 and D 2…”
Get full text

Rotigotine treatment partially protects from MPTP toxicity in a progressive macaque model of Parkinson's disease by Scheller, Dieter, Chan, Piu, Li, Qin, Wu, Tao, Zhang, Renling, Guan, Le, Ravenscroft, Paula, Guigoni, Celine, Crossman, Alan R., Hill, Michael, Bezard, Erwan

“…Clinical DA agonist monotherapy trials, which used in vivo imaging of the DA transporter (DAT) to assess the rate of progression of nigrostriatal degeneration,…”
Get full text

Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning by Guigoni, Céline, Dovero, Sandra, Aubert, Incarnation, Li, Qin, Bioulac, Bernard H., Bloch, Bertrand, Gurevich, Eugenia V., Gross, Christian E., Bezard, Erwan

“…The extent of nigrostriatal denervation is presumed to play a role in the genesis of levodopa‐induced dyskinesia. Yet some parkinsonian patients who have been…”
Get full text

Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates by Guigoni, Céline, Doudnikoff, Evelyne, Li, Qin, Bloch, Bertrand, Bezard, Erwan

“…Dyskinesias represent a debilitating complication of levodopa therapy for Parkinson's disease (PD). While we recently demonstrated that levodopa-induced…”
Get full text

Rabies virus is not cytolytic for rat spinal motoneurons in vitro by Guigoni, Céline, Coulon, Patrice

“…Cultures of purified rat embryonic spinal cord motoneurons were used to investigate the capacity of the neurons to survive rabies virus infection in vitro . In…”
Get full text

Dopamine-deprived striatal GABAergic interneurons burst and generate repetitive gigantic IPSCs in medium spiny neurons by Dehorter, Nathalie, Guigoni, Celine, Lopez, Catherine, Hirsch, June, Eusebio, Alexandre, Ben-Ari, Yehezkel, Hammond, Constance

“…Striatal GABAergic microcircuits modulate cortical responses and movement execution in part by controlling the activity of medium spiny neurons (MSNs). How…”
Get more information

Striatal overexpression of DeltaJunD resets L-DOPA-induced dyskinesia in a primate model of Parkinson disease by Berton, Olivier, Guigoni, Céline, Li, Qin, Bioulac, Bernard H, Aubert, Incarnation, Gross, Christian E, Dileone, Ralph J, Nestler, Eric J, Bezard, Erwan

“…Involuntary movements, or dyskinesia, represent a debilitating complication of dopamine replacement therapy for Parkinson disease (PD). The transcription…”
Get full text

Phenotype of striatofugal medium spiny neurons in parkinsonian and dyskinetic nonhuman primates: a call for a reappraisal of the functional organization of the basal ganglia by Nadjar, Agnes, Brotchie, Jonathan M, Guigoni, Celine, Li, Qin, Zhou, Shao-Bo, Wang, Gui-Jie, Ravenscroft, Paula, Georges, François, Crossman, Alan R, Bezard, Erwan

“…The classic view of anatomofunctional organization of the basal ganglia is that striatopallidal neurons of the "indirect" pathway express D2 dopamine receptors…”
Get more information

Impact of chronic subthalamic high-frequency stimulation on metabolic basal ganglia activity: a 2-deoxyglucose uptake and cytochrome oxidase mRNA study in a macaque model of Parkinson's disease by Meissner, Wassilios, Guigoni, Celine, Cirilli, Laetitia, Garret, Maurice, Bioulac, Bernard H., Gross, Christian E., Bezard, Erwan, Benazzouz, Abdelhamid

“…The mechanisms of action of high‐frequency stimulation (HFS) of the subthalamic nucleus (STN) remain only partially understood. Hitherto, experimental studies…”
Get full text

Striatal Overexpression of JunD Resets L-DOPA-Induced Dyskinesia in a Primate Model of Parkinson Disease by Berton, Olivier, Guigoni, Celine, Li, Qin, Bioulac, Bernard H, Aubert, Incarnation, Gross, Christian E, DiLeone, Ralph J, Nestler, Eric J, Bezard, Erwan

“…Involuntary movements, or dyskinesia, represent a debilitating complication of dopamine replacement therapy for Parkinson disease (PD). The transcription…”
Get full text

SHORT COMMUNICATION: Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning by Guigoni, Celine, Dovero, Sandra, Aubert, Incarnation, Li, Qin, Bioulac, Bernard H, Bloch, Bertrand, Gurevich, Eugenia V, Gross, Christian E, Bezard, Erwan

“…The extent of nigrostriatal denervation is presumed to play a role in the genesis of levodopa-induced dyskinesia. Yet some parkinsonian patients who have been…”
Get full text

Increased D sub(1) dopamine receptor signaling in levodopa-induced dyskinesia by Aubert, Incarnation, Guigoni, Celine, Haakansson, Kerstin, Li, Qin, Dovero, Sandra, Barthe, Nicole, Bioulac, Bernard H, Gross, Christian E, Fisone, Gilberto, Bloch, Bertrand, Bezard, Erwan

“…Involuntary movements, or dyskinesia, represent a debilitating complication of levodopa therapy for Parkinson's disease. Although changes affecting D sub(1)…”
Get full text